Plain-English translation of NCT05704582 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new virtual reality-based intervention designed to help people with psychotic disorders (like schizophrenia or bipolar disorder with psychotic symptoms) reduce their cannabis use. Instead of learning abstract strategies, you would practice real-world coping techniques in a virtual environment with avatars. The trial compares this new approach to standard supportive counseling to see which works better at reducing cannabis cravings and improving quality of life.
People with psychotic disorders who use cannabis are at high risk of being hospitalized and experience worse depression, medication problems, and lower quality of life. Unfortunately, there are no proven treatments specifically designed for cannabis use disorder in this population, so this new treatment aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You would attend 8 weekly sessions lasting about 60 minutes each over 2 months, with the option of up to 4 additional sessions if needed. Depending on which group you're randomly assigned to, you would either use a virtual reality program with avatars to practice coping skills, or receive standard supportive counseling focused on reducing cannabis cravings. The trial will track your cannabis use, symptoms, and quality of life over time.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Canada